BioSpace News Archive

Patients in areas across the country now have access to Deep Transcranial Magnetic Stimulation (Deep TMS) therapy as an aid for short-term smoking cessation

Oracle Leader Bob Weiler Joins Board of Directors; Biopharma Market Access and Commercial Expert Dr. Amy Grogg Joins CEO Advisory Board from AmerisourceBergen

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced that the U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research has launched a Phase 2 clinical trial in Thailand to evaluate ImmunityBio’s interleukin-15 (IL-15) superagonist Anktiva®

The US-manufactured, cost-effective nHale™, can be used with or without supplemental oxygen in-hospital, at-home, and in field hospitals

Recently, Revotek Co., Ltd., a vertically integrated biotech company specialized in 3D bioprinting, and West China Hospital of Sichuan University, a leading research hospital in China, have reached an agreement, in which the latter shall introduce Revotek’s cell encapsulation technology, or Biosynsphere, for the use in its basic and translational research in stem cell regenerative medicine.

Valted Seq, a biotechnology company focused on the discovery of neurodegenerative pathways and biomarkers to inform and accelerate development of new therapeutics and diagnostics, today announced an exclusive right to evaluate technology from Johns Hopkins University for development of poly(ADP-ribose) (PAR) and c-Abl pathway biomarker assays to enable diagnosis and management of neurodegenerative diseases.

Cerapedics Inc., an ortho-biologics company dedicated to enhancing the science of bone repair, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its investigational P-15L Bone Graft for the treatment of degenerative disc disease (DDD).

Results showed 100% sensitivity and reduced time to diagnosis by an estimated 65.5%, with potential to improve pathologists’ workflow in a real-world environment

AMRA Medical (“AMRA”), a global leader in body composition analysis, announced today that Barbara J. Dalton, Ph. D. has been appointed to its Board of Directors

Sirnaomics Biopharmaceuticals (Suzhou) Co. Ltd., a subsidiary of Sirnaomics, Inc ., a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer, fibrotic diseases and viral infections, announced today that the company has entered into a partnership agreement with Walvax Biotechnology